Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Five Stocks To Buy: Adani Power, Glenmark Pharma, Tata Steel And More | July 7, 2026
Market analysts and brokerage firms have identified high-conviction trading ideas for the upcoming session, focusing on power, pharma, auto sector and chemicals.
Astral's demerger plan triggers sharp selloff, brokerages trim target prices
Astral's stock dipped 11% after announcing a demerger of its chemicals business. Investors are concerned about the valuation and growth prospects of the standalone chemical entity, which currently lags the profitable plumbing segment. While analysts maintain 'buy' ratings, some have lowered target prices. The company anticipates significant revenue growth for the chemicals division in the coming years.
10 smallcap stocks soar up to 212% this year, 3 turn multibaggers. Do you own any?
India's smallcap stocks have outperformed the Nifty 50 in 2026, with HFCL, Aditya Infotech and Acutaas Chemicals leading the top 10 performers, delivering exceptional year-to-date returns.
Logistics player A1 expands industrial chemical portfolio
A 1 Ltd, a logistics and chemical supplier, has been appointed the Primary Authorised Dealer for Ishan Dyes and Chemicals Ltd's sulphur-based industrial chemicals. This strategic move significantly expands A 1 Ltd's product offerings, including vital chemicals like Sulphuric Acid and Oleum, serving diverse sectors such as fertilisers and pharmaceuticals.
Netweb Technologies India Ltd leads losers in 'A' group
Persistent Systems Ltd, Astral Ltd, Supreme Industries Ltd and Alkyl Amines Chemicals Ltd are among the other losers in the BSE's 'A' group today, 29 June 2026.
Can Astral's demerger catalyze chemicals growth?
Astral's chemicals demerger sharpens business focus, but investors remain unconvinced. The key question is whether the spin-off can revive margins and justify the stock's rich valuation.
Astral slides as board OKs chemicals biz demerger
Astral tumbled 8.20% to Rs 1,364.45 after the company's board approved the demerger of its chemicals business into a separate entity, Astral Chemie and the amalgamation of wholly owned subsidiary Al-Aziz Plastics.
Astral falls 7% on chemicals business demerger announcement; time to buy?
Astral demerger: Notably, the company informed the exchanges that its board has approved a scheme to demerge its chemicals business into a separately listed company.
Astral Shares Fall Over 6% After Demerger Plan; Chemicals Business To Be Listed Separately
Astral Shares Drop Over 6% After Business Restructuring
Astral shares drop 6% after demerger. What should investors do?
Astral shares fell nearly 6% on Monday after the company’s board approved the demerger of its chemicals business into a newly incorporated entity, Astral Chemie. According to an exchange filing, the Composite Scheme of Arrangement also includes Astral Limited and Al-Aziz Plastics. The stock hit a low of Rs 1,389 amid the development and approval process.
Astral shares in focus on demerger news but JPMorgan downgrades; check price targets
Another brokerage firm CLSA said the demerger is unlikely to have a meaningful impact on the stock in the near term, adding that sustained growth and margin improvement in the chemicals business will be the key drivers for any future rerating.
Missed the FII U-turn? 6 stocks turned multibagger after foreign investors corrected their mistake
Foreign institutional investors (FIIs) reversed their selling trend in six select Indian stocks, turning them into multibaggers. Bajaj Consumer Care led the pack with a 265% surge after FIIs significantly increased their stake. Other beneficiaries include Acutaas Chemicals, SML Mahindra, Dee Development Engineers, United Foodbrands, and RateGain Travel Technologies, all witnessing substantial gains following FII re-entry. This shift highlights smart money's strategic course correction.